7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Oh ES et al. | Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women. | 2005 | Metab. Clin. Exp. | pmid:15562379 |
| Rajzbaum G et al. | French women, fractures and aortic calcifications. | 2005 | J. Intern. Med. | pmid:15606383 |
| Xing L et al. | Osteoclast precursors, RANKL/RANK, and immunology. | 2005 | Immunol. Rev. | pmid:16313338 |
| Tanaka S et al. | Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. | 2005 | Immunol. Rev. | pmid:16313339 |
| Horowitz MC et al. | B cells and osteoblast and osteoclast development. | 2005 | Immunol. Rev. | pmid:16313346 |
| Clowes JA et al. | The role of the immune system in the pathophysiology of osteoporosis. | 2005 | Immunol. Rev. | pmid:16313351 |
| Al-Fakhri N et al. | Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification. | 2005 | Thromb. Haemost. | pmid:16411417 |
| Jiang J et al. | LTB4 can directly stimulate human osteoclast formation from PBMC independent of RANKL. | 2005 | Artif Cells Blood Substit Immobil Biotechnol | pmid:16317958 |
| Galluzzi F et al. | Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. | 2005 | Eur. J. Endocrinol. | pmid:16322394 |
| Raisz LG | Pathogenesis of osteoporosis: concepts, conflicts, and prospects. | 2005 | J. Clin. Invest. | pmid:16322775 |
| Kieslinger M et al. | EBF2 regulates osteoblast-dependent differentiation of osteoclasts. | 2005 | Dev. Cell | pmid:16326388 |
| Yamazaki H and Sasaki T | Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice. | 2005 | J Electron Microsc (Tokyo) | pmid:16339792 |
| Wang YD et al. | [Predominant effect of bushen ningxin decoction on postmenopausal osteoporosis in mice]. | 2005 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:16355616 |
| Pantsulaia I et al. | Contribution of the familial and genetic factors on monocyte chemoattractant protein-1 variation in healthy human pedigrees. | 2005 | Cytokine | pmid:16213155 |
| Low E et al. | Expression of mRNA for osteoprotegerin and receptor activator of nuclear factor kappa beta ligand (RANKL) during root resorption induced by the application of heavy orthodontic forces on rat molars. | 2005 | Am J Orthod Dentofacial Orthop | pmid:16214633 |
| Schneeweis LA et al. | Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand. | 2005 | J. Biol. Chem. | pmid:16215261 |
| Bezerra MC et al. | Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. | 2005 | Rheumatology (Oxford) | pmid:16219645 |
| Zwerina J et al. | Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption. | 2005 | FASEB J. | pmid:16234431 |
| Viereck V et al. | Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts. | 2005 | J. Bone Miner. Res. | pmid:16234977 |
| Gajewska J et al. | [The impairement of bone formation and resorption in 25-year-old man with neglected celiac disease]. | 2005 | Wiad. Lek. | pmid:16238129 |
| Ruocco MG and Karin M | IKK{beta} as a target for treatment of inflammation induced bone loss. | 2005 | Ann. Rheum. Dis. | pmid:16239395 |
| Xiao HL et al. | [Expression and activity determination of TNFR domain of osteoprotegerin in E.coli and corresponding antibody preparation]. | 2005 | Yi Chuan | pmid:16257908 |
| Liu W et al. | Receptor activator of NF-kappaB (RANK) cytoplasmic motif, 369PFQEP373, plays a predominant role in osteoclast survival in part by activating Akt/PKB and its downstream effector AFX/FOXO4. | 2005 | J. Biol. Chem. | pmid:16260781 |
| Hormdee D et al. | Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts. | 2005 | Clin. Exp. Immunol. | pmid:16297161 |
| Burton DW et al. | Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP. | 2005 | Prostate | pmid:15389781 |
| Zahanich I et al. | Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells. | 2005 | J. Bone Miner. Res. | pmid:16059635 |
| Cao JJ et al. | Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. | 2005 | J. Bone Miner. Res. | pmid:16059637 |
| Terpos E et al. | The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio. | 2005 | Leukemia | pmid:16079895 |
| von Knoch F et al. | Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. | 2005 | J Biomed Mater Res A | pmid:16088891 |
| Li J et al. | [Effect of raloxifene and estradiol on the biological function and osteoprotegerin expression of osteoblasts in vitro]. | 2005 | Di Yi Jun Yi Da Xue Xue Bao | pmid:16027068 |
| Pipes GD et al. | Optimization and applications of CDAP labeling for the assignment of cysteines. | 2005 | Pharm. Res. | pmid:16028006 |
| Yang S et al. | Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts. | 2005 | J. Immunol. | pmid:16034140 |
| Mangashetti LS et al. | IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling. | 2005 | J. Immunol. | pmid:16002690 |
| Lukić IK et al. | Alteration of newly induced endochondral bone formation in adult mice without tumour necrosis factor receptor 1. | 2005 | Clin. Exp. Immunol. | pmid:15654822 |
| Subramaniam M et al. | TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. | 2005 | Mol. Cell. Biol. | pmid:15657444 |
| Olesen P et al. | Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha. | 2005 | Diabetologia | pmid:15700136 |
| Pantouli E et al. | Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15721297 |
| Korcok J et al. | P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts. | 2005 | J. Biol. Chem. | pmid:15722352 |
| Kiviranta R et al. | Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. | 2005 | Bone | pmid:15664014 |
| Avbersek-Luznik I et al. | Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? | 2005 | Nephrol. Dial. Transplant. | pmid:15665031 |
| Schneider HG and Sentry J | Multiple myeloma. | 2005 | N. Engl. J. Med. | pmid:15736296 |
| Mesquita M et al. | Bone cytokines and renal osteodystrophy in peritoneal dialysis patients. | 2005 | Adv Perit Dial | pmid:16686314 |
| Glass DA et al. | Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. | 2005 | Dev. Cell | pmid:15866165 |
| Grzegorzewska AE and Mlot M | Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients. | 2005 | Adv Perit Dial | pmid:16686316 |
| Valenta A et al. | Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats. | 2005 | Bone | pmid:15869920 |
| Chan MH et al. | Specific biochemical markers of bone metabolism and cytokine study confirm the diagnosis of malignant infantile osteopetrosis at birth using cord blood sample. | 2005 | Pathology | pmid:15875734 |
| Seminari E et al. | Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients. | 2005 | HIV Med. | pmid:15876279 |
| Abrahamsen B et al. | Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins. | 2005 | Bone | pmid:15781001 |
| Schett G et al. | Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models. | 2005 | Arthritis Rheum. | pmid:15880601 |
| Zhao HY et al. | The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. | 2005 | Osteoporos Int | pmid:15782282 |
| Moe SM et al. | Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). | 2005 | Kidney Int. | pmid:15882271 |
| Bezerra MC et al. | RANK, RANKL and osteoprotegerin in arthritic bone loss. | 2005 | Braz. J. Med. Biol. Res. | pmid:15785827 |
| Ueland T et al. | Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. | 2005 | Circulation | pmid:15883214 |
| Stilgren LS et al. | [The cytokine system of bone tissue]. | 2005 | Ugeskr. Laeg. | pmid:15789838 |
| Sabokbar A et al. | Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. | 2005 | J. Orthop. Res. | pmid:15885469 |
| Fukushima H et al. | Parathyroid-hormone-related protein induces expression of receptor activator of NF-{kappa}B ligand in human periodontal ligament cells via a cAMP/protein kinase A-independent pathway. | 2005 | J. Dent. Res. | pmid:15790738 |
| Morony S et al. | The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy. | 2005 | Endocrinology | pmid:15845617 |
| Konduri K et al. | Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression. | 2005 | Clin Lymphoma | pmid:15794867 |
| Rhee EJ et al. | The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women. | 2005 | Am. J. Obstet. Gynecol. | pmid:15846185 |
| Bord S et al. | Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. | 2005 | Bone | pmid:15794927 |
| Rasmussen LM and Ledet T | Osteoprotegerin and diabetic macroangiopathy. | 2005 | Horm. Metab. Res. | pmid:15918117 |
| Tanabe N et al. | IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts. | 2005 | Life Sci. | pmid:15921993 |
| Zhou YQ et al. | [OPG and OPGL expression in condyle cartilage of temporomandibular joint following anterior disc displacement]. | 2005 | Shanghai Kou Qiang Yi Xue | pmid:16155701 |
| Crisafulli A et al. | Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction. | 2005 | Clin. Sci. | pmid:15926884 |
| Holen I et al. | Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival? | 2005 | Breast Cancer Res. Treat. | pmid:16155791 |
| Mahamed DA et al. | G(-) anaerobes-reactive CD4+ T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice. | 2005 | Diabetes | pmid:15855336 |
| Mazziotti G et al. | Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. | 2005 | J. Bone Miner. Res. | pmid:15746993 |
| Corey E et al. | Osteoprotegerin in prostate cancer bone metastasis. | 2005 | Cancer Res. | pmid:15753366 |
| Moschen AR et al. | The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. | 2005 | Gut | pmid:15753532 |
| Liu D et al. | Chronology and regulation of gene expression of RANKL in the rat dental follicle. | 2005 | Eur. J. Oral Sci. | pmid:16202028 |
| Bhattacharya A et al. | Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids. | 2005 | J Am Coll Nutr | pmid:15930486 |
| Xie F et al. | Increase in bone mass and bone strength by Sambucus williamsii HANCE in ovariectomized rats. | 2005 | Biol. Pharm. Bull. | pmid:16204939 |
| Juarranz Y et al. | Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis. | 2005 | Arthritis Res. Ther. | pmid:16207319 |
| Kerschan-Schindl K et al. | Serum levels of cathepsin K decrease with age in both women and men. | 2005 | Exp. Gerontol. | pmid:15935595 |
| Görtz B et al. | Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo. | 2005 | Arthritis Res. Ther. | pmid:16207331 |
| Ugur-Altun B et al. | The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity. | 2005 | Diabetes Res. Clin. Pract. | pmid:15936463 |
| Kostenuik PJ | Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. | 2005 | Curr Opin Pharmacol | pmid:16188502 |
| Whang PG et al. | The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone. | 2005 | J. Orthop. Res. | pmid:16005175 |
| Sakakura Y et al. | Immunolocalization of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice. | 2005 | J. Anat. | pmid:16191162 |
| Oh KW et al. | Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males. | 2005 | Clin. Endocrinol. (Oxf) | pmid:15638876 |
| Bashir A et al. | Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene. | 2005 | Steroids | pmid:16005483 |
| Meng XM et al. | [Expression of receptor activator of NF-kappa B ligand and osteoprotegerin protein in the giant cell lesions of jaw]. | 2005 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:16191370 |
| Khosla S | Magic bullets to kill nasty osteoclasts. | 2005 | Endocrinology | pmid:16009971 |
| Tabuchi M et al. | Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice. | 2005 | Calcif. Tissue Int. | pmid:16193235 |
| Ketteler M et al. | "Missing" inhibitors of calcification: general aspects and implications in renal failure. | 2005 | Pediatr. Nephrol. | pmid:15549415 |
| Feng X | RANKing intracellular signaling in osteoclasts. | 2005 | IUBMB Life | pmid:16012047 |
| Kusumi A et al. | Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain. | 2005 | J. Bone Miner. Metab. | pmid:16133687 |
| Moran CS et al. | Association of osteoprotegerin with human abdominal aortic aneurysm progression. | 2005 | Circulation | pmid:15939823 |
| Deftos LJ | Treatment of Paget's disease--taming the wild osteoclast. | 2005 | N. Engl. J. Med. | pmid:16135831 |
| Li F et al. | Annexin II stimulates RANKL expression through MAPK. | 2005 | J. Bone Miner. Res. | pmid:15940368 |
| Cundy T et al. | Recombinant osteoprotegerin for juvenile Paget's disease. | 2005 | N. Engl. J. Med. | pmid:16135836 |
| Sen O et al. | The relation between serum levels of osteoprotegerin and postoperative epidural fibrosis in patients who underwent surgery for lumbar disc herniation. | 2005 | Neurol. Res. | pmid:15949247 |
| Rhee EJ et al. | Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein. | 2005 | Clin. Sci. | pmid:15569000 |
| Bock O et al. | Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin. | 2005 | Br. J. Haematol. | pmid:15982347 |
| Heinrich J et al. | CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption. | 2005 | Arch. Oral Biol. | pmid:16137499 |
| Fiore CE et al. | Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system. | 2005 | Osteoporos Int | pmid:15983730 |
| Avignon A et al. | Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. | 2005 | Diabetes Care | pmid:16123486 |
| Atkins GJ et al. | Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. | 2005 | J. Cell. Physiol. | pmid:15573398 |
| Amizuka N et al. | Histological evaluation for "bone quality" on two mouse models with different bone remodeling. | 2005 | J. Bone Miner. Metab. | pmid:15984413 |
| Ziegler S et al. | Endurance running acutely raises plasma osteoprotegerin and lowers plasma receptor activator of nuclear factor kappa B ligand. | 2005 | Metab. Clin. Exp. | pmid:15988704 |